Skip to main content

Therapeutics Startups

Updated November 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,733 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,733
Total Funding
$1.9B
Avg Funding
$75.1M
Global Reach
7
countries

Top Cities for Therapeutics

San Diego
Bristol
San Francisco
Boston
Paris
Houston

Recently Funded Companies

Export
San Diego, United States

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

$300.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Bristol, United Kingdom

Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform.

$4.4M raised
May 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.

$13.2M raised
May 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Anagram Therapeutics develops orally delivered enzyme therapies for malabsorption syndromes and nutrient deficiencies.

$250.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Paris, France

Signadori Bio is the next-generation cellular immunotherapy for cancer cure.

$13.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Houston, United States

Autoimmunity BioSolutions develops a future immuno-corrective treatment that restores healthy immune function.

$1.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

May 2026

Founder Contacts

41,000+ verified contacts

Rockville, United States

Avalo Therapeutics is a clinical-stage biopharmaceutical company.

$431.3M raised
May 2026

Founder Contacts

41,000+ verified contacts

Paris, France

Abivax develops medicines that alter the body's natural immune system mechanisms.

$45.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Göteborg, Sweden

IRLAB Therapeutics is a drug discovery and development company providing novel treatments for disorders of the brain.

$11.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Montreal, Canada

CELYSTRA Pharma identifies, licenses, and commercializes innovative therapies for rare and underserved diseases in Canada.

$14.7M raised
May 2026

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

$150.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Rockville, United States

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies.

$11.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.

$43.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Illumina Radiopharmaceuticals

$2.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Houston, United States

CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.

$22.5M raised
May 2026

Founder Contacts

41,000+ verified contacts

Newton, United States

Inflammasome Therapeutics develops therapies for prevalent, degenerative diseases like Alzheimer’s disease and Parkinson's disease.

$13.2M raised
May 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

$550K raised
May 2026

Founder Contacts

41,000+ verified contacts

Saint-herblain, France

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

$43.1M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

New Haven, United States

VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions.

$384.4M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Berlin, Germany

Tacalyx is a biotech company that develops therapies that target cancer by focusing on tumor-associated carbohydrate antigens.

$12.9M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Axoft is a revolutionary seamless interface between brain and machine.

$55.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Pasadena, United States

AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS.

$7.5M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Fathom Therapeutics focuses on drug design by harnessing biomolecular motion to develop therapeutics that can reprogram protein function.

$47.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Allschwil, Switzerland

Cancentus is a cancer treatment company that provides AI-based disease discovery solutions.

$636K raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Showing 226 to 250 of 1,733 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,733 therapeutics companies tracked in the VCBacked database.

Average Funding
$75.1M
Total Funding Tracked
$1.9B
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.Paris
2 companies$58.0M
2.Houston
2 companies$23.5M
3.South San Francisco
2 companies$550K
4.Rockville
2 companies$442.3M
5.Philadelphia
2 companies$193.0M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

1,733 Therapeutics Startups (2026) — Recently Funded — Page 10 | VCBacked